Lung Cancer · LIVING RESEARCH LIBRARY

Ongoing Research for Lung Cancer Using Advanced Alternative Medicine

Explore positive published findings by substance, cancer biology, treatment interaction and quality-of-life outcome.

Every entry includes the original study title, year, concise finding and a direct PubMed link.

Call 1.800.923.7878

Ask About Your Lung Cancer Case

Tell us the diagnosis, stage, biomarkers, current treatment plan and research questions you want to understand. Our Patient Care Team will follow up personally.

Prefer to speak now?
Call 1.800.923.7878

Living research library · positive published findings

Research organized by substance and finding

Browse 19 source-linked studies with the full title, publication year, research focus and a concise finding. Select any linked substance to move directly to its corresponding Sunridge page.

Dihydroartemisinin inhibits lung cancer bone metastasis by modulating macrophage polarization.

2025 · Metastasis and invasion

In vitro, DHA was found to inhibit M2 polarization while promoting M1 polarization of macrophages, thereby reducing the invasion and migration of lung cancer cells.

Open study on PubMed →

Berberine regulates PADI4-related macrophage function to prevent lung cancer.

2022 · Immune and inflammatory signaling

Berberine at the experiment dose had no effect on cell viability of U937-derived macrophages, but could significantly inhibit PADI4 expression to reverse the macrophage-activated state and the lung cancer -promoting effect of PADI4-overexpressed macrophages.

Open study on PubMed →

Curcumin suppresses lung cancer progression via circRUNX1 mediated miR-760/RAB3D axis.

2023 · Metastasis and invasion

Curcumin reduced LC cell proliferation, metastasis, and accelerate apoptosis, while circRUNX1 overexpression reversed these effects.

Open study on PubMed →

EGCG alleviates obesity-exacerbated lung cancer progression by STAT1/SLC7A11 pathway and gut microbiota.

2023 · Immune and inflammatory signaling

Currently, we found that leptin-triggered M2 polarization of tumor-associated macrophages was inhibited by EGCG.

Open study on PubMed →

Compound K-enriched Korean red ginseng prevents lung cancer progression by targeting cancer cells and fibroblasts.

2025 · Tumor growth and proliferation

Recently, we developed a CK-enriched red ginseng extract (CKP) and explored its potential to suppress lung cancer by inhibiting cancer cell proliferation and inactivating fibroblasts.

Open study on PubMed →

Ginsenoside Rh2 as a novel PIN1 inhibitor disrupting the cancer stem cell-like phenotype in non-small cell lung cancer.

2025 · Metastasis and invasion

G-Rh2 inhibited CSC-like properties in NSCLC cells, reduced tumor metastasis, and enhanced sensitivity to both chemotherapy and GF treatment.

Open study on PubMed →

Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer.

2024 · Metastasis and invasion

Treatment with G-Rh2 significantly inhibited tumor proliferation and migration ability both in vitro and in vivo.

Open study on PubMed →

Particulate matter-induced lung cancer metastasis is inhibited by ginsenoside Rg3.

2025 · Metastasis and invasion

The aim of this study was to elucidate the mechanism underlying PM-induced cancer metastasis and investigate the preventive role of ginsenoside Rg3.

Open study on PubMed →

Melatonin Downregulates PD-L1 Expression and Modulates Tumor Immunity in KRAS-Mutant Non-Small Cell Lung Cancer.

2021 · Apoptosis and cell death

In the present study, melatonin treatment significantly reduced cell viability accompanied by inducing cell apoptosis in KRAS-mutant NSCLC cell lines including A549, H460, and LLC1 cells.

Open study on PubMed →

Mistletoe lectin inhibits growth of Myc-amplified small-cell lung cancer.

2023 · Apoptosis and cell death

We found that ML treatment inhibits growth of SCLC cell lines in culture and induces apoptosis.

Open study on PubMed →

Profiling the tumor-resident microbiota in small cell lung cancer and its influence on clinical outcomes.

2026 · Cancer biology and response

The intersection of survival and response results identify Clostridium and Lactobacillus as promising prognostic tumor microbiota markers in SCLC.

Open study on PubMed →

Pulmonary microbiome and metabolome signatures associate with chemotherapy response in lung cancer patients.

2025 · Treatment response

Microbiome analysis revealed differential abundances of specific bacterial genera, particularly increased Caulobacter and decreased Acinetobacter in sensitive patients.

Open study on PubMed →

The Microbiome in Lung Cancer Tissue and Recurrence-Free Survival.

2019 · Survival and clinical response

We explored associations of tumor or normal tissue microbiome diversity and composition with recurrence-free (RFS) and disease-free survival (DFS), and compared microbiome diversity and composition between paired tumor and normal samples.

Open study on PubMed →

Quercetin induces pro-apoptotic autophagy via SIRT1/AMPK signaling pathway in human lung cancer cell lines A549 and H1299 in vitro.

2021 · Apoptosis and cell death

Quercetin inhibited cell viability and induced mitochondria-dependent apoptosis in both A549 and H1299 cells in a dose-dependent.

Open study on PubMed →

In vivo mechanisms of resveratrol liposomes in targeting the TLR4/NLRP3 pathway in lung cancer.

2025 · Metastasis and invasion

Resveratrol liposome significantly inhibited lung cancer cell proliferation and migration, and induced apoptosis in orthotopic lung cancer models.

Open study on PubMed →

Resveratrol Derivatives Inhibit Pro-survival Akt Signaling Pathway in Lung Cancer.

2025 · Apoptosis and cell death

This study aimed to modify and improve resveratrol's efficacy by enhancing apoptosis induction in non-small cell lung cancer.

Open study on PubMed →

Exploring the anti-cancer and antimetastatic effect of Silymarin against lung cancer.

2024 · Metastasis and invasion

Furthermore, MTT assays revealed a dose-dependent inhibition of cell proliferation upon silymarin treatment and found the IC50 value at 58 μM.

Open study on PubMed →

Pharmacological Ascorbate Elicits Anti-Cancer Activities against Non-Small Cell Lung Cancer through Hydrogen-Peroxide-Induced-DNA-Damage.

2023 · Cancer biology and response

Non-small cell lung cancer (NSCLC) poses a significant global health burden with unsatisfactory survival rates, despite advancements in diagnostic and therapeutic modalities.

Open study on PubMed →

Vitamin D and SIRT1 activator SRT2104 cooperate in antiproliferative activity in lung cancer through ferroptosis induction.

2025 · Apoptosis and cell death

We further revealed that vitamin D and SIRT1 activator SRT2104 cooperate in inhibiting lung cancer cells proliferation.

Open study on PubMed →

Scottsdale Clinic

14200 N Northsight Blvd #160
Scottsdale, Arizona 85260

Office Hours

Monday–Friday: 9:00 AM–5:00 PM
Saturday: 9:00 AM–12:00 PM

Visit Sunridge in Scottsdale

FREE INTRODUCTORY CALL

Speak With Our Patient Care Team

Tell us what you are facing. There is no charge to speak with our Patient Care Team, understand how Sunridge works and determine whether a physician consultation may be an appropriate next step.

Call Now: 1-800-923-7878

This introductory call is not a medical consultation and does not establish a physician-patient relationship.

Have a Question or Share Feedback:
It's easy to get in touch with us